Eydenzelt is subjecting Eylea to further biosimilar erosion, though Regeneron hopes to offset this with two new approvals for ...
The proportion of children receiving a second dose of the MMR vaccine is still below the threshold to stop viral transmission ...
With an eye on 2026, the healthcare editorial team reflects on key takeaways and trends from recent pharma conferences.
In 2024, over half of patients found to have HIV in Europe received a late diagnosis, which is often associated with poor ...
The UK MHRA has granted approval to Roche Products’ inavolisib to treat adults diagnosed with HR-positive, HER2-negative ...
IASO Biotechnology has received the Hong Kong Department of Health approval for its BLA submitted for the fully human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback